Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 134 Lung Neoplasms 50 Breast Neoplasms 24 Head and Neck Neoplasms 22 Adenocarcinoma of Lung 18 Brain Neoplasms 15 Neoplasms 14 Adenocarcinoma, Bronchiolo-Alveolar 11 Squamous Cell Carcinoma of Head and Neck 10 Glioblastoma 9 Esophageal Neoplasms 9 Colorectal Neoplasms 9 NSCLC 8 Rectal Neoplasms 7 Prostatic Neoplasms 7 Neoplasm Metastasis 7 Gliosarcoma 7 Colonic Neoplasms 7 Adenocarcinoma Of Esophagus 7 Ovarian Neoplasms 5 Esophageal Squamous Cell Carcinoma 5 Adenocarcinoma 5 Urinary Bladder Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Renal Cell 4 Carcinoma 4 Unspecified Adult Solid Tumor, Protocol Specific 3 Skin Neoplasms 3 Respiratory Tract Diseases 3 Kidney Neoplasms 3

Interventions

Cyclophosphamide 153 Dexamethasone 141 Rituximab 85 fludarabine 79 Lenalidomide 72 Cytarabine 70 Bortezomib 64 fludarabine phosphate 63 Gemcitabine 62 venetoclax 54 Etoposide 53 pomalidomide 52 pembrolizumab 52 Paclitaxel 48 Cisplatin 48 Carboplatin 48 Peripheral Blood Stem Cell Transplantation 47 Filgrastim 40 Radiotherapy 39 Busulfan 37 Calcium Dobesilate 36 Methotrexate 34 Melphalan 34 Bevacizumab 33 carfilzomib 32 Cyclosporine 32 Azacitidine 32 Mycophenolic Acid 30 Vincristine 29 Bendamustine Hydrochloride 29

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Gefitinib × Clear all

NCT00824746 2013-02-26

ReGaiN

Chonnam National University Hospital

Phase 2 Completed

23 enrolled 9 charts

Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡